Van Cleef Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,825
Closed -$678K 120
2019
Q3
$678K Sell
6,825
-2,975
-30% -$283K 0.15% 69
2019
Q2
$906K Sell
9,800
-600
-6% -$57K 0.2% 61
2019
Q1
$981K Sell
10,400
-100
-1% -$8.75K 0.23% 56
2018
Q4
$673K Hold
10,500
0.18% 64
2018
Q3
$940K Hold
10,500
0.21% 53
2018
Q2
$834K Sell
10,500
-1,300
-11% -$108K 0.2% 58
2018
Q1
$1.05M Sell
11,800
-125
-1% -$12K 0.26% 50
2017
Q4
$1.24M Sell
11,925
-1,225
-9% -$138K 0.31% 50
2017
Q3
$1.92M Buy
13,150
+100
+0.8% +$13.6K 0.52% 38
2017
Q2
$1.7M Sell
13,050
-100
-0.8% -$12.3K 0.49% 37
2017
Q1
$1.64M Hold
13,150
0.5% 39
2016
Q4
$1.52M Hold
13,150
0.49% 41
2016
Q3
$1.38M Hold
13,150
0.46% 41
2016
Q2
$1.3M Buy
13,150
+400
+3% +$41.4K 0.45% 43
2016
Q1
$1.28M Sell
12,750
-250
-2% -$25.7K 0.45% 42
2015
Q4
$1.56M Buy
13,000
+50
+0.4% +$5.79K 0.57% 38
2015
Q3
$1.4M Hold
12,950
0.55% 39
2015
Q2
$1.5M Hold
12,950
0.56% 38
2015
Q1
$1.49M Sell
12,950
-150
-1% -$17.9K 0.56% 39
2014
Q4
$1.47M Buy
13,100
+850
+7% +$89.6K 0.54% 40
2014
Q3
$1.16M Hold
12,250
0.48% 42
2014
Q2
$1.05M Hold
12,250
0.44% 42
2014
Q1
$855K Hold
12,250
0.37% 44
2013
Q4
$1.03M Hold
12,250
0.46% 41
2013
Q3
$944K Sell
12,250
-200
-2% -$14K 0.47% 42
2013
Q2
$728K Buy
+12,450
New +$749K 0.38% 47

Other funds holding CELG

Van Cleef Asset Management's CELG Position: Q4 2019 in Review

Van Cleef Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,825 shares — an estimated $678K sold.

Van Cleef Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.92M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Van Cleef Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Van Cleef Asset Management sold 6,825 Celgene Corp shares in Q4 2019, an estimated $678K.
  • Van Cleef Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Van Cleef Asset Management's Celgene Corp position peaked at $1.92M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Van Cleef Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.